STEVEN FOGELMAN: Open Payments
NPI 1821137712 · ROME, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$79,496 in 77 payments from 4 companies in 2025. Trend: 2023 $62,317 · 2024 $40,490 · 2025 $79,496
Speaker / faculty: $65,314Consulting: $6,400Travel & lodging: $5,923Food & beverage: $1,859
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 58 | $59,823 |
| ABBVIE INC. | 17 | $19,491 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $57 |
Products named: INGREZZA, VRAYLAR, CAPLYTA, Auvelity.
Industry payments across NY — which companies pay providers there.
